Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran

Author(s): Mansour Babaei, Behzad Heidari, Hossein Ghorbani, Zahra Ahmadnia, Samaneh Rouhi and Mahmoud Sadeghi Haddad Zavareh*

Volume 24, Issue 6, 2024

Published on: 09 February, 2024

Article ID: e090224226818 Pages: 6

DOI: 10.2174/0118715265209731240129042916

Price: $65

Abstract

Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19.

Materials and Methods: Data were collected from hospitalized patients (May to June 2020), and COVID-19 was confirmed in patients by real-time polymerase chain reaction (PCR). The patient group was classified into survivor and deceased groups. The chi-square and the independent t-test with Statistical Package for the Social Sciences (SPSS) software program, version 18, were used for analysis.

Results: Mean age, hemoglobin, serum C-reactive protein (CRP), alkaline phosphatase (ALP), white blood cells, and level of procalcitonin in non-survivors were significantly higher than in survivors. Serum tumour necrosis factor-alpha (TNF-a) had a significant relationship with Ddimer (p = 0.0006). The risk of mortality in patients with serum CRP ≥ 100 mg/dl was significantly higher than those with CRP < 100 mg/dl (odds ratio (OR) = 4.8 (95% CI, 1.33-12.44, p = 0.01).

Conclusion: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.

Graphical Abstract

[1]
Xiong S, Liu L, Lin F, et al. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: A single-centered, retrospective, observational study. BMC Infect Dis 2020; 20(1): 787.
[http://dx.doi.org/10.1186/s12879-020-05452-2] [PMID: 33092539]
[2]
Perincek G, Avci S. A case series of patients with COVID-19 infection admitted to a secondary care center in Turkey. Front Emerg Med 2020; 4(2s): e49.
[3]
Mostafa A, Kandil S, El-Sayed MH, et al. Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers. Int J Epidemiol 2021; 50(1): 50-61.
[http://dx.doi.org/10.1093/ije/dyaa173] [PMID: 33094320]
[4]
Kochhar A, Pande D, Saini S, Ganapathy U, Gogia A. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian J Palliat Care 2020; 26(5) (Suppl. 1): 36.
[http://dx.doi.org/10.4103/IJPC.IJPC_146_20] [PMID: 33088084]
[5]
Ozma MA, Maroufi P, Khodadadi E, et al. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med 2020; 28(2): 153-65.
[PMID: 32275257]
[6]
Li M, Zhang Z, Cao W, et al. Identifying novel factors associated with COVID-19 transmission and fatality using the machine learning approach. Sci Total Environ 2021; 764: 142810.
[http://dx.doi.org/10.1016/j.scitotenv.2020.142810 ] [PMID: 33097268]
[7]
Macera M, De Angelis G, Sagnelli C, Coppola N. Vanvitelli COVID-group. clinical presentation of COVID-19: Case series and review of the literature. Int J Environ Res Public Health 2020; 17(14): 5062.
[http://dx.doi.org/10.3390/ijerph17145062] [PMID: 32674450]
[8]
Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID -19. Med J Aust 2020; 213(3): 134-9.
[http://dx.doi.org/10.5694/mja2.50698] [PMID: 32677734]
[9]
Dennis JM, Mateen BA, Sonabend R, et al. Type 2 diabetes and COVID-19-related mortality in the critical care setting: A national cohort study in England, March-July 2020. Diabetes Care 2021; 44(1): 50-7.
[http://dx.doi.org/10.2337/dc20-1444] [PMID: 33097559]
[10]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395(10229): 1054-62.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3 ] [PMID: 32171076]
[11]
Gu T, Mack JA, Salvatore M, et al. Characteristics Associated with racial/ethnic disparities in covid-19 outcomes in an academic health care system. JAMA Netw Open 2020; 3(10): e2025197.
[http://dx.doi.org/10.1001/jamanetworkopen.2020.25197 ] [PMID: 33084902]
[12]
Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis. Arch Acad Emerg Med 2020; 8(1): e35.
[PMID: 32232218]
[13]
Godri Pollitt KJ, Peccia J, Ko AI, et al. COVID-19 vulnerability: The potential impact of genetic susceptibility and airborne transmission. Hum Genomics 2020; 14(1): 17.
[http://dx.doi.org/10.1186/s40246-020-00267-3 ] [PMID: 32398162]
[14]
Ahmed A, Ali A, Hasan S. Comparison of epidemiological variations in COVID-19 patients inside and outside of China-A meta-analysis. Front Public Health 2020; 193.
[http://dx.doi.org/10.3389/fpubh.2020.00193]
[15]
Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2021; 93(3): 1449-58.
[http://dx.doi.org/10.1002/jmv.26424] [PMID: 32790106]
[16]
Tian W, Jiang W, Yao J, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020; 92(10): 1875-83.
[http://dx.doi.org/10.1002/jmv.26050] [PMID: 32441789]
[17]
Alnor A, Sandberg MB, Gils C, Vinholt PJ. Laboratory tests and outcome for patients with coronavirus disease 2019: A systematic review and meta-analysis. J Appl Lab Med 2020; 5(5): 1038-49.
[http://dx.doi.org/10.1093/jalm/jfaa098] [PMID: 32573713]
[18]
Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020; 96: 467-74.
[http://dx.doi.org/10.1016/j.ijid.2020.05.055] [PMID: 32425643]
[19]
Udomsinprasert W, Jittikoon J, Sangroongruangsri S, Chaikledkaew U. Circulating LEVELS OF interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis. J Clin Immunol 2021; 41(1): 11-22.
[http://dx.doi.org/10.1007/s10875-020-00899-z] [PMID: 33128665]
[20]
Rostamian A, Ghazanfari T, Arabkheradmand J, et al. Interleukin-6 as a potential predictor of COVID-19 disease severity in hospitalized patients and its association with clinical laboratory routine tests. Immunoregulation 2020; 3(1): 29-36.
[http://dx.doi.org/10.32598/IMMUNOREGULATION.3.1.4]
[21]
Robinson PC, Liew DFL, Liew JW, et al. The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med 2020; 1(1): 90-102.
[http://dx.doi.org/10.1016/j.medj.2020.11.005] [PMID: 33294881]
[22]
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020; 14(4): 395-403.
[http://dx.doi.org/10.1016/j.dsx.2020.04.018] [PMID: 32334395]
[23]
Sepandi M, Taghdir M, Alimohamadi Y, Afrashteh S, Hosamirudsari H. Factors associated with mortality in covid-19 patients: A systematic review and meta-analysis. Iran J Public Health 2020; 49(7): 1211-21.
[http://dx.doi.org/10.18502/ijph.v49i7.3574 ] [PMID: 33083287]
[24]
Mehraeen E, Karimi A, Barzegary A, et al. Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med 2020; 40: 101226.
[http://dx.doi.org/10.1016/j.eujim.2020.101226]
[25]
Macedo A, Gonçalves N, Febra C. COVID-19 fatality rates in hospitalized patients: Systematic review and meta-analysis. Ann Epidemiol 2021; 57(57): 14-21.
[http://dx.doi.org/10.1016/j.annepidem.2021.02.012 ] [PMID: 33662494]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy